AGGRENOX (Dipyridamole/ASA)(aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is an antiplatelet agent for patients with prior ischemic stroke or TIA. AGGRENOX (Dipyridamole/ASA) is an antiplatelet combination used to prevent strokes in patients who have had transient ischemia or ischemic stroke due to blood clots. AGGRENOX (Dipyridamole/ASA) may also be used to treat other conditions as determined by your doctor.
AGGRENOX side effects, that may go away during treatment, include stomach pain, headache, heartburn, dizziness, or constipation. If AGGRENOX side effects continue or are bothersome, check with your doctor. CHECK WITH YOUR DOCTOR AS SOON AS POSSIBLE if you experience AGGRENOX side effects like severe stomach pain; nausea; vomiting; bloody or black, tarry stools; vomiting of blood; rash; swelling of hands, face, lips, eyes, throat, or tongue; difficulty swallowing or breathing; hoarseness; yellowing of the skin or eyes; dark urine or pale stools; or unusual fatigue. If you notice other AGGRENOX side effects not listed above, contact your doctor, nurse, or pharmacist.
AGGRENOX Information WARNING: Children and teenagers should not use aspirin, aspirin- containing or aspirin-related medicines for flu symptoms or chickenpox without first consulting a doctor. A rare but serious illness known as Reye's syndrome may occur. Some medicines or medical conditions may interact with this medicine. INFORM YOUR DOCTOR OR PHARMACIST of all prescription and over-the-counter medicine that you are taking. DO NOT TAKE THIS MEDICINE if you are also taking probenecid or sulfinpyrazone. ADDITIONAL MONITORING OF YOUR DOSE OR CONDITION may be needed if you are taking an anticoagulant, methotrexate, valproic acid, or oral medicine for glaucoma (carbonic anhydrase inhibitors) or diabetes. Inform your doctor of any other medical conditions including asthma, nasal polyps, any allergies - especially aspirin/NSAID allergy (e.g., ibuprofen, celecoxib), pregnancy, or breast-feeding. Contact your doctor or pharmacist if you have any questions or concerns about AGGRENOX Information.
For further information, please refer to: http://www.aggrenox-asasantin.com/com/splashscreen.jsp